XLV 📈 Health Care Sector SPDR Fund - Overview
Exchange: NYSE ARCA • Opening Hours • Country: USA • Currency: USD • Type: Etf • ISIN: US81369Y2090 • Health
XLV: Drugs, Medical Devices, Hospitals, Biotech, Lab Equipment, Healthcare IT
The Health Care Select Sector SPDR Fund (NYSE ARCA:XLV) is an exchange-traded fund (ETF) that aims to replicate the performance of a specific index. To achieve this, the fund invests at least 95% of its total assets in the securities that make up the index, using a replication strategy.
The index is comprised of companies from a range of health care-related industries, including pharmaceuticals, health care equipment and supplies, health care providers and services, biotechnology, life sciences tools and services, and health care technology. This diversified portfolio allows investors to gain exposure to the overall health care sector, rather than focusing on a single industry or company.
As a non-diversified fund, the Health Care Select Sector SPDR Fund may invest a larger portion of its assets in a smaller number of securities, which can increase its potential returns but also increases its risk. However, by tracking a specific index, the fund provides investors with a cost-effective way to gain exposure to the health care sector, which can be an attractive option for those looking to diversify their portfolios.
For more information about the fund, investors can visit the company's website at http://www.spdrs.com. The fund is domiciled in the United States and is listed on the NYSE ARCA under the ticker symbol XLV.
Additional Sources for XLV ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
XLV ETF Overview
Market Cap in USD | 38,525m |
Category | Health |
TER | 0.09% |
IPO / Inception | 1998-12-16 |
XLV ETF Ratings
Growth 5y | 75.7 |
Fundamental | - |
Dividend | 44.9 |
Rel. Performance vs Sector | -1.65 |
Analysts | - |
Fair Price Momentum | 135.73 USD |
Fair Price DCF | - |
XLV Dividends
Dividend Yield 12m | 1.59% |
Yield on Cost 5y | 2.49% |
Dividends CAGR 5y | -0.25% |
Payout Consistency | 96.01% |
XLV Growth Ratios
Growth Correlation 3m | -92% |
Growth Correlation 12m | 83.1% |
Growth Correlation 5y | 91% |
CAGR 5y | 9.37% |
CAGR/Mean DD 5y | 2.19 |
Sharpe Ratio 12m | 0.63 |
Alpha vs SP500 12m | -13.46 |
Beta vs SP500 5y weekly | 0.75 |
Volatility GJR Garch 1y | 18.09% |
Current Volume | 9328.3k |
Average Volume 20d | 7498.6k |
As of November 21, 2024, the stock is trading at USD 142.88 with a total of 9,328,300 shares traded.
Over the past week, the price has changed by -2.69%, over one month by -5.58%, over three months by -7.13% and over the past year by +12.49%.
Yes. Based on ValueRay Analyses, Health Care Sector SPDR Fund (NYSE ARCA:XLV) is currently (November 2024) a good stock to buy. It has a ValueRay Growth Rating of 75.67 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XLV as of November 2024 is 135.73. This means that XLV is currently overvalued and has a potential downside of -5%.
Health Care Sector SPDR Fund has no consensus analysts rating.
According to ValueRays Forecast Model, XLV Health Care Sector SPDR Fund will be worth about 149.7 in November 2025. The stock is currently trading at 142.88. This means that the stock has a potential upside of +4.79%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 149.7 | 4.8% |